Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
14.53 (1y: +40%)
Market Cap 181.6 M P/E(ttm) 47.80
Enterprise Value 158.81 M P/B 2.60
ROCM- NAS (USA)
Rochester Medical Corporation
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$14.53
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry		 vs
history
Cash to Debt No Debt
ROCM's Cash to Debt is ranked higher than
96% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. ROCM: No Debt )
ROCM' s 10-Year Cash to Debt Range
Min: 0.31   Max: No Debt
Current: No Debt
Equity to Asset 0.899
ROCM's Equity to Asset is ranked higher than
94% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. ROCM: 0.899 )
ROCM' s 10-Year Equity to Asset Range
Min: 0.64   Max: 0.95
Current: 0.9
0.64
0.95
Interest Coverage 68.4
ROCM's Interest Coverage is ranked higher than
79% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. ROCM: 68.4 )
ROCM' s 10-Year Interest Coverage Range
Min: 13   Max: No Debt
Current: 68.4
F-Score: 7
Z-Score: 17.88
M-Score: -2.93
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) 5.20
ROCM's Operating margin (%) is ranked higher than
67% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.50 vs. ROCM: 5.20 )
ROCM' s 10-Year Operating margin (%) Range
Min: -77.9   Max: 8.8
Current: 5.2
-77.9
8.8
Net-margin (%) 3.3
ROCM's Net-margin (%) is ranked higher than
67% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. ROCM: 3.3 )
ROCM' s 10-Year Net-margin (%) Range
Min: -70.4   Max: 104.2
Current: 3.3
-70.4
104.2
ROE (%) 3
ROCM's ROE (%) is ranked higher than
65% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. ROCM: 3 )
ROCM' s 10-Year ROE (%) Range
Min: -25.6   Max: 52.8
Current: 3
-25.6
52.8
ROA (%) 2.7
ROCM's ROA (%) is ranked higher than
67% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. ROCM: 2.7 )
ROCM' s 10-Year ROA (%) Range
Min: -23.8   Max: 45.1
Current: 2.7
-23.8
45.1
ROC (Joel Greenblatt) (%) 11.00
ROCM's ROC (Joel Greenblatt) (%) is ranked higher than
68% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. ROCM: 11.00 )
ROCM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -48.9   Max: 13.8
Current: 11
-48.9
13.8
Revenue Growth (%) 16.1
ROCM's Revenue Growth (%) is ranked higher than
95% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.80 vs. ROCM: 16.1 )
ROCM' s 10-Year Revenue Growth (%) Range
Min: 6.3   Max: 19.1
Current: 16.1
6.3
19.1
EBITDA Growth (%) 52
ROCM's EBITDA Growth (%) is ranked higher than
99% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ROCM: 52 )
ROCM' s 10-Year EBITDA Growth (%) Range
Min: -48   Max: 52
Current: 52
-48
52
EPS Growth (%) 103.1
ROCM's EPS Growth (%) is ranked higher than
99% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ROCM: 103.1 )
ROCM' s 10-Year EPS Growth (%) Range
Min: -50.8   Max: 155.5
Current: 103.1
-50.8
155.5
ยป ROCM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

ROCM Guru Trades in Q2 2012

Jim Simons 101,900 sh (+6.81%)
Mario Gabelli 619,424 sh (+2.24%)
» More
Q3 2012

ROCM Guru Trades in Q3 2012

Mario Gabelli 646,324 sh (+4.34%)
Jim Simons 89,800 sh (-11.87%)
» More
Q4 2012

ROCM Guru Trades in Q4 2012

Mario Gabelli 639,224 sh (-1.1%)
Jim Simons 79,300 sh (-11.69%)
» More
Q1 2013

ROCM Guru Trades in Q1 2013

Robert Bruce 84,800 sh (New)
Jim Simons 76,900 sh (-3.03%)
Mario Gabelli 536,120 sh (-16.13%)
» More
» Details

Insider Trades

Latest Guru Trades with ROCM

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2011-03-31 Reduce -49.2%0.05%$10.03 - $11.29 $ 14.5336%632624
Mario Gabelli 2010-09-30 Add 186.57%0.03%$8.56 - $11.17 $ 14.5353%1155190
Mario Gabelli 2010-06-30 Add 332.13%0.02%$9.44 - $13.12 $ 14.5330%403114
Premium More recent guru trades are included for Premium Members only!!
ยป Financial Charts

Peter Lynch Chart

Top Ranked Articles about Rochester Medical Corporation

Guru Mario Gabelli Reduces ROCM, US Direct Sales Up 41%
April 15, 2013
Mario Gabelli - Guru Mario Gabelli Reduces ROCM, US Direct Sales Up 41%
As of April 11, 2013, GAMCO Investorsโ€™ Chairman and CEO Mario Gabelli reduced his position by 12.85% in the Rochester Medical Corporation (ROCM). Gabelli currently holds 522,510 shares after the trade. The average price range was $14.72, making a 0.01% impact on his portfolio. The current ROCM share price is $14.47 with a change from average down 2%. This trade is Gabelliโ€™s second reduction of ROCM in the last month. As of March 31, 2012, Gabelli cut his position by 49.2% at an average price of $10.65 per share. Rochester Medical Corporation has a market cap of $170.5 million. The P/E is 54.6, the P/B is 2.5 and the P/S is 2.6. The stock is up 35% since January. Read more...

Ratios

vs
industry		 vs
history
P/E(ttm) 47.80
ROCM's P/E(ttm) is ranked lower than
53% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.00 vs. ROCM: 47.80 )
ROCM' s 10-Year P/E(ttm) Range
Min: 4.09   Max: 507.67
Current: 47.8
4.09
507.67
P/B 2.60
ROCM's P/B is ranked higher than
65% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. ROCM: 2.60 )
ROCM' s 10-Year P/B Range
Min: 1.2   Max: 6.22
Current: 2.6
1.2
6.22
P/S 2.70
ROCM's P/S is ranked higher than
60% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.48 vs. ROCM: 2.70 )
ROCM' s 10-Year P/S Range
Min: 1.52   Max: 11.03
Current: 2.7
1.52
11.03
PFCF 25.90
ROCM's PFCF is ranked higher than
67% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.54 vs. ROCM: 25.90 )
ROCM' s 10-Year PFCF Range
Min: 3.37   Max: 1293
Current: 25.9
3.37
1293
EV-to-EBIT 28.6
ROCM's EV-to-EBIT is ranked higher than
50% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.13 vs. ROCM: 28.6 )
ROCM' s 10-Year EV-to-EBIT Range
Min: 21.2   Max: 2573.4
Current: 28.6
21.2
2573.4
PEG 1.6
ROCM's PEG is ranked higher than
76% of the 106 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.89 vs. ROCM: 1.6 )
ROCM' s 10-Year PEG Range
Min: 0.13   Max: 98.39
Current: 1.6
0.13
98.39
Shiller P/E 213.8
ROCM's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: vs. ROCM: 213.8 )
ROCM' s 10-Year Shiller P/E Range
Min: 12.32   Max: 216.7
Current: 213.8
12.32
216.7

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 13.6
ROCM's Price/Net Cash is ranked lower than
61% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. ROCM: 13.6 )
ROCM' s 10-Year Price/Net Cash Range
Min: 4.6   Max: 21.7
Current: 13.6
4.6
21.7
Price/Net Current Asset Value 12.4
ROCM's Price/Net Current Asset Value is ranked higher than
62% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.20 vs. ROCM: 12.4 )
ROCM' s 10-Year Price/Net Current Asset Value Range
Min: 7.2   Max: 21.9
Current: 12.4
7.2
21.9
Price/Tangible Book 3.6
ROCM's Price/Tangible Book is ranked higher than
56% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.70 vs. ROCM: 3.6 )
ROCM' s 10-Year Price/Tangible Book Range
Min: 1.4   Max: 10.3
Current: 3.6
1.4
10.3
Price/DCF (Projected) 2.5
ROCM's Price/DCF (Projected) is ranked lower than
63% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. ROCM: 2.5 )
ROCM' s 10-Year Price/DCF (Projected) Range
Min: 0.7   Max: 5.4
Current: 2.5
0.7
5.4
Price/Median PS Value 0.7
ROCM's Price/Median PS Value is ranked higher than
87% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. ROCM: 0.7 )
ROCM' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.8
Current: 0.7
0.5
1.8
Price/Peter Lynch Fair Value 1.9
ROCM's Price/Peter Lynch Fair Value is ranked higher than
52% of the 56 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.80 vs. ROCM: 1.9 )
ROCM' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.3   Max: 19.8
Current: 1.9
0.3
19.8
Price/Graham Number 3.7
ROCM's Price/Graham Number is ranked lower than
78% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. ROCM: 3.7 )
ROCM' s 10-Year Price/Graham Number Range
Min: 1.1   Max: 12.8
Current: 3.7
1.1
12.8
Earnings Yield (Greenblatt) 3.50
ROCM's Earnings Yield (Greenblatt) is ranked higher than
66% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.90 vs. ROCM: 3.50 )
ROCM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 4.7
Current: 3.5
0.2
4.7
Forward Rate of Return (Yacktman) 36.64
ROCM's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 272 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ROCM: 36.64 )
ROCM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.2   Max: 41.7
Current: 36.64
-13.2
41.7

Business Description

Rochester Medical Corporation was incorporated in the State of Minnesota in 1988. The Company develops, manufactures and markets, domestically and internationally, a broad line of innovative, technologically enhanced PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Acute care markets are generally hospitals and extended care treatment facilities, while home care users are generally patients who use the Company's products at home. It also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace. The main purchasers of the Company's products are distributors, individual hospitals and healthcare institutions, and extended care facilities. It markets its products under the Company's Rochester Medical brand through a direct sales force in the United States, the United Kingdom and the Netherlands, and through independent distributors in other international markets. The Company also markets its Rochester Medical branded products to Group Purchasing Organizations. It competes directly for sales of continence care devices under its own Rochester Medical brand with larger, multi-product medical device manufacturers and distributors such as C.R. Bard, Inc., Unomedical A/S, Covidien PLC, Hollister and Coloplast. The manufacture and sale of its products are subject to regulation by numerous governmental authorities, principally the FDA and corresponding foreign agencies.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
ยป More Articles for ROCM

Headlines

Articles On GuruFocus.com
Guru Mario Gabelli Reduces ROCM, US Direct Sales Up 41% Apr 15 2013 
comment on ROCM Jan 26 2013 
Euro Stocks Are Cheap Sep 10 2012 
Baron Funds Comments on Roche Holding May 24 2012 
Rochester Medical Corp. (ROCM) CFO and Treasurer David A Jonas sells 40,000 Shares Feb 18 2011 
Rochester Medical Corp. Reports Operating Results (10-Q) Feb 08 2011 
Rochester Medical Corp. Reports Operating Results (10-Q) Aug 06 2010 
Rochester Medical Corp. Reports Operating Results (10-Q) Feb 09 2010 
Rochester Medical Corp. Reports Operating Results (10-Q) Aug 10 2009 
Rochester Medical Corp. Reports Operating Results (10-Q) May 08 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK